Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Low Genit Tract Dis. 2016 Jan;20(1):31–37. doi: 10.1097/LGT.0000000000000165

Table 3.

Sites with On-site Screening and Treatment Available by HIV status#

HIV-infected
n=37
HIV-uninfected
n=29
SCREENING
 VIA 29(78) 24(83)
 Pap 25(68) 19(66)
 HPV DNA 13(35) 10(34)
 VILI 10(27) 9(31)
 Colposcopy +/− biopsy 4(11) 3(10)
TREATMENT
 None 3(8) 1(3)
Premalignant lesions
 Cryotherapy 27(73) 21(72)
 LEEP 21(57) 17(59)
 Conization 12(32) 10(34)
Malignant lesions
 Radical or extended hysterectomy 18(49) 16(55)
 Chemotherapy 9(24) 10(34)
 Radiation therapy 5(14) 5(17)

Data are n(%)

*

Sites may report more than one screening and treatment method

#

Sites may be included in both HIV-infected and HIV-uninfected women columns if sites report screening and treatment programs regardless of HIV status.

Pap – Papanicolaou test, VIA -visual inspection with acetic acid, VILI - visual inspection with Lugol’s solution, HPV – human papilloma virus DNA test